Ergoteles’s Axonics, Inc. Common Stock AXNX Stock Holding History

Ergoteles’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-56,086	Closed	-$3.18M	–	2089
2022 Q2	$3.18M	Buy	56,086 +41,725	+291%	+$2.29M	0.1%	216
2022 Q1	$899K	Buy	14,361 +10,563	+278%	+$569K	0.03%	468
2021 Q4	$213K	Buy	+3,798	New	+$232K	0.01%	1003
2021 Q1	–	Sell	-18,100	Closed	-$904K	–	1120
2020 Q4	$904K	Buy	+18,100	New	+$850K	0.03%	350

Other funds holding AXNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ergoteles's AXNX Position: Q3 2022 in Review

Ergoteles sold out of Axonics, Inc. Common Stock (AXNX) in Q3 2022, closing a stake of 56,086 shares — an estimated $3.18M sold.

Ergoteles first reported a position in AXNX in Q4 2020 and held it in 4 quarters. The position peaked at $3.18M in Q2 2022. 230 funds tracked by Wall St. Rank hold AXNX as of Q3 2022.

Ergoteles reported no remaining Axonics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Ergoteles sold 56,086 Axonics, Inc. Common Stock shares in Q3 2022, an estimated $3.18M.
Ergoteles first reported a position in Axonics, Inc. Common Stock in Q4 2020 and held it in 4 quarters.
Ergoteles's Axonics, Inc. Common Stock position peaked at $3.18M in Q2 2022.
230 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q3 2022.

Based on Ergoteles's 13F filing for Q3 2022, filed 14 Nov 2022.